Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

NICE recommends against Opdivo for classical Hodgkin lymphoma

pharmafileMarch 16, 2017

Tag: Opdivo , Hodgkin lymphoma

PharmaSources Customer Service